The framework promotes risk stratification integrating omics, clinical history, environmental exposures, and behavior, alongside continuous monitoring enabled by digital tools and biomarkers to anticipate health decline, and social determinants are embedded to ensure feasibility and equity.
S. Boccia, S. Farina, E. Giacobini et al.· European Journal of Public H...· 0 citations
The SRIA outlines the key areas that must be addressed in order to fully realise the potential of personalised prevention within European health systems and identifies a comprehensive set of 56 goals and 66 actions aimed at strengthening evidence generation, interoperability, real-world implementation and capacity buil...
S. Boccia, R. Pastorino· European Journal of Public H...· 0 citations
Abstract Background Despite advances in genomics for cancer prevention, its clinical utility remains inadequately assessed. This study, conducted within the European Joint Action JANE2, synthesizes evidence on the clinical utility of genomic-based personalized preventive strategies. Methods We conducted a systematic re...
A. Sabatelli, S. Farina, E. Giacobini et al.· European Journal of Public H...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.